Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince ...

An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...

While an argument to re-integrate JavaFX floats in an OpenJDK discussion list, Oracle ponders providing better access to JavaFX from the JDK.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Mojang is ending the obfuscation of Minecraft Java Edition's code very soon, which will make it easier than ever to create ...

Microsoft introduced a new video series that teaches Java developers how to build generative AI applications using modern ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Well over a decade has passed since the release of Mojang 's monumental sandbox game Minecraft, with countless mods dropping ...